AI-Enabled Diagnosis and Prognosis of Hypertrophic Cardiomyopathy — Stella

Clinical trial discovery in plain English. Data sourced from ClinicalTrials.gov.

About Browse conditions ClinicalTrials.gov ↗

Stella is not a medical provider and does not give medical advice. AI-generated summaries are for informational purposes only. Always consult your doctor before making any healthcare decisions.

AI-Enabled Diagnosis and Prognosis of Hypertrophic Cardiomyopathy — Stella

Home/Hypertrophic Cardiomyopathy (HCM)/

View on ClinicalTrials.gov

Recruiting

Back to Hypertrophic Cardiomyopathy (HCM) trials

Trial locations(1 site)

China

Second Affiliated Hospital, Zhejiang University School of Medicine, Hangzhou, Zhejiang

Key details

Sponsor

Second Affiliated Hospital, School of Medicine, Zhejiang University

Enrollment target

~15,000 participants

Started

January 2025

Primary completion

June 2026

Age range

18 Years and older

Last updated December 2025

Interested in joining?

Tell us you're interested and we'll help connect you with the research team. We'll never share your email without your permission.

Your name

Email address

Stella acts as an intermediary. Researcher contact info is never exposed.

Follow this trial

Get notified in plain English when this trial's status changes. No account required.